Holen Sie sich die Stockscreener-App
87.73
0.00%
0.12
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$87.61
Offen:
$87.93
24-Stunden-Volumen:
438.30K
Relative Volume:
0.04
Marktkapitalisierung:
$218.93B
Einnahmen:
$63.43B
Nettoeinkommen (Verlust:
$16.42B
KGV:
13.53
EPS:
6.4861
Netto-Cashflow:
$14.72B
1W Leistung:
-2.80%
1M Leistung:
+4.19%
6M Leistung:
+10.97%
1J Leistung:
-19.27%
1-Tages-Spanne:
$87.33
$87.93
1-Wochen-Bereich:
$87.14
$91.00
52-Wochen-Spanne:
$73.31
$111.58
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
87.65 | 218.83B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
854.92 | 756.28B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
189.02 | 454.91B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
231.73 | 411.31B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
132.84 | 254.66B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Castle Rock Wealth Management LLC Buys Shares of 25,125 Merck & Co., Inc. $MRK - MarketBeat
Guild Investment Management Inc. Invests $3.18 Million in Merck & Co., Inc. $MRK - MarketBeat
Secured Retirement Advisors LLC Purchases Shares of 12,504 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Louisiana State Employees Retirement System - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
Merck, Doctors Reject Proposal To Break Up Combined MMR VaccineMerck & Co (NYSE:MRK) - Benzinga
KLP Kapitalforvaltning AS Has $102.21 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Shell Asset Management Co. Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Godsey & Gibb Inc. Buys 6,790 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co starts phase IIb study of tulisokibart in rheumatoid arthritis - MarketScreener
Merck Completes Acquisition of Verona Pharma - Business Wire
Seamount Financial Group Inc. Purchases Shares of 4,550 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Grimes & Company Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by SteelPeak Wealth LLC - MarketBeat
Merck Expands Tulisokibart Development In Pipeline-In-A-Product Race - insights.citeline.com
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - Benzinga
Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk - The Globe and Mail
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases - Stock Titan
Merck & Co., Inc. $MRK Shares Bought by Cullinan Associates Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Position Raised by Plimoth Trust Co. LLC - MarketBeat
Merit Financial Group LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ascent Group LLC Sells 38,049 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK): A Bull Case Theory - MSN
OLD National Bancorp IN Acquires 46,762 Shares of Merck & Co., Inc. $MRK - MarketBeat
Simplicity Wealth LLC Buys 52,381 Shares of Merck & Co., Inc. $MRK - MarketBeat
Chemung Canal Trust Co. Buys 15,861 Shares of Merck & Co., Inc. $MRK - MarketBeat
Highland Capital Management LLC Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Talbot Financial LLC Buys 40,512 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bernstein Maintains a Hold Rating on Merck & Co (MRK) - MSN
ZWJ Investment Counsel Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
AMF Tjanstepension AB Sells 1,453,467 Shares of Merck & Co., Inc. $MRK - MarketBeat
Penobscot Investment Management Company Inc. Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Bank Hapoalim BM Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by NTV Asset Management LLC - MarketBeat
Precedent Wealth Partners LLC Acquires 3,259 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ameritas Advisory Services LLC Sells 3,732 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck: A Race Against The Keytruda Clock (NYSE:MRK) - Seeking Alpha
What Does Wall Street Think About Merck & Co. (MRK)? - MSN
Sterling Investment Counsel LLC Has $474,000 Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Boosted by Synergy Asset Management LLC - MarketBeat
Syntax Research Inc. Sells 30,028 Shares of Merck & Co., Inc. $MRK - MarketBeat
Hilltop National Bank Buys Shares of 10,618 Merck & Co., Inc. $MRK - MarketBeat
MRK November 14th Options Begin Trading - Nasdaq
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? - Yahoo Finance
Cliftonlarsonallen Wealth Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Robeco Institutional Asset Management B.V. Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Community Financial Services Group LLC Sells 42,545 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR - Insider Monkey
Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial - MSN
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 - PharmiWeb.com
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):